Suppr超能文献

胃癌中DNA倍体模式和S期分数预后意义的回顾性分析。

Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.

作者信息

Yonemura Y, Ooyama S, Sugiyama K, Kamata T, De Aretxabala X, Kimura H, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I

机构信息

Department of Surgery II, School of Medicine, Kanazawa University, Japan.

出版信息

Cancer Res. 1990 Feb 1;50(3):509-14.

PMID:2297693
Abstract

Paraffin-embedded tumor samples from 493 gastric carcinoma patients were analyzed by DNA flow cytometry. The results were correlated with clinicopathological findings and S-phase fractions measured by in vivo bromodeoxyuridine (BrdUrd) labeling. Of the 493 patients, 183 (37%), 225 (46%), and 85 (17%) showed diploidy, single DNA-aneuploidy, and DNA-multiploidy patterns, respectively. When the DNA histogram and all the clinicopathological parameters were entered simultaneously into the Cox regression model, DNA ploidy, liver metastasis, peritoneal dissemination, and nodal status emerged as independent prognostic parameters. The relative risk of death was twofold higher in single DNA-aneuploid and threefold higher in DNA-multiploid tumors than in DNA-diploid tumors. BrdUrd labeling indices (LIs) also proved to be an independent prognostic factor. Multiploid tumors showed the highest median BrdUrd LI associated with the most frequent peritoneal dissemination and liver metastasis. The simultaneous evaluation of DNA ploidy patterns and BrdUrd LIs gave more prognostic information than the determination of tumor DNA ploidy only. Namely, DNA diploid, together with low BrdUrd LIs, was associated with favorable prognosis, whereas DNA aneuploid with high BrdUrd LIs was related to the poorest prognosis. These results indicate that DNA ploidy and BrdUrd labeling indices may be possibly useful prognostic factors for gastric carcinoma.

摘要

对493例胃癌患者的石蜡包埋肿瘤样本进行了DNA流式细胞术分析。将结果与临床病理结果以及通过体内溴脱氧尿苷(BrdUrd)标记测量的S期分数进行关联。在这493例患者中,分别有183例(37%)、225例(46%)和85例(17%)表现出二倍体、单DNA非整倍体和DNA多倍体模式。当将DNA直方图和所有临床病理参数同时纳入Cox回归模型时,DNA倍体、肝转移、腹膜播散和淋巴结状态成为独立的预后参数。单DNA非整倍体肿瘤的相对死亡风险是DNA二倍体肿瘤的两倍,DNA多倍体肿瘤的相对死亡风险是DNA二倍体肿瘤的三倍。BrdUrd标记指数(LIs)也被证明是一个独立的预后因素。多倍体肿瘤显示出最高的中位BrdUrd LI,与最频繁的腹膜播散和肝转移相关。同时评估DNA倍体模式和BrdUrd LIs比仅测定肿瘤DNA倍体提供了更多的预后信息。也就是说,DNA二倍体与低BrdUrd LIs相关,预后良好,而DNA非整倍体与高BrdUrd LIs相关,预后最差。这些结果表明,DNA倍体和BrdUrd标记指数可能是胃癌有用的预后因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验